BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31822801)

  • 21. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
    Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
    Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KMT2D and TP53 mutation status improve the prognostic value of the International Prognostic Index (IPI) stratification in ENKTL patients.
    Gao Y; Li Y; Ma G; Zhao G; Liu H
    Neoplasma; 2020 May; 67(3):636-643. PubMed ID: 32064880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
    Chou CC; Tsao CF; Liao CK; You HL; Wang MC; Huang WT
    Exp Mol Pathol; 2021 Feb; 118():104577. PubMed ID: 33242451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HKDC1 C-terminal based peptides inhibit extranodal natural killer/T-cell lymphoma by modulation of mitochondrial function and EBV suppression.
    Chen Q; Feng J; Wu J; Yu Z; Zhang W; Chen Y; Yao P; Zhang H
    Leukemia; 2020 Oct; 34(10):2736-2748. PubMed ID: 32203147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome.
    Kato S; Hamada M; Okamoto A; Yamashita D; Miyoshi H; Arai H; Satou A; Gion Y; Sato Y; Tsuyuki Y; Miyata-Takata T; Takata K; Asano N; Takahashi E; Ohshima K; Tomita A; Hosoda W; Nakamura S; Okuno Y
    Blood Adv; 2024 May; 8(9):2138-2147. PubMed ID: 38429084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type.
    Hong J; Park S; Baek HL; Jung JH; Kang IG; Sym SJ; Park J; Ahn JY; Cho EK; Kim ST; Shin DB; Lee JH
    Int J Clin Exp Pathol; 2012; 5(9):939-47. PubMed ID: 23119111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of T-cell receptor expression in EBV-positive neoplastic cells in extranodal NK/T-cell lymphoma, nasal-type, and comparison with T-cell receptor gene rearrangement by BIOMED-2 assay.
    Takayama T; Shin S; Kang S; Kim SJ; Kim WS; Ko YH
    Hum Pathol; 2018 Mar; 73():51-58. PubMed ID: 29258904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
    Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma.
    Cho J; Kim SJ; Park S; Yoo KH; Ki CS; Ko Y; Kim WS
    Ann Hematol; 2018 Aug; 97(8):1427-1436. PubMed ID: 29627879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
    Wang XX; Li PF; Bai B; Gao Y; Rong QX; Cai QQ; Lin SX; Zhang YJ; Li ZM; Jiang WQ; Huang HQ
    Leuk Lymphoma; 2019 Aug; 60(8):1917-1925. PubMed ID: 30646796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma.
    Peng RJ; Han BW; Cai QQ; Zuo XY; Xia T; Chen JR; Feng LN; Lim JQ; Chen SW; Zeng MS; Guo YM; Li B; Xia XJ; Xia Y; Laurensia Y; Chia BKH; Huang HQ; Young KH; Lim ST; Ong CK; Zeng YX; Bei JX
    Leukemia; 2019 Jun; 33(6):1451-1462. PubMed ID: 30546078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.
    Lee S; Park HY; Kang SY; Kim SJ; Hwang J; Lee S; Kwak SH; Park KS; Yoo HY; Kim WS; Kim JI; Ko YH
    Oncotarget; 2015 Jul; 6(19):17764-76. PubMed ID: 25980440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.
    Pongpruttipan T; Kummalue T; Bedavanija A; Khuhapinant A; Ohshima K; Arakawa F; Niino D; Sukpanichnant S
    Diagn Pathol; 2011 Aug; 6():79. PubMed ID: 21867533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
    Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
    Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of the 30 base pair deletion of Epstein-Barr virus latent membrane protein 1 in extranodal nasal type NK/T-cell lymphoma and its prognostic significance].
    Zhao S; Liu WP; Wang XL; Zhang WY; Jiang W; Tang Y; Li GD
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):720-3. PubMed ID: 16536316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin.
    Kim SJ; Kim JH; Ki CS; Ko YH; Kim JS; Kim WS
    Ann Oncol; 2016 Mar; 27(3):508-13. PubMed ID: 26658891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.
    Motsch N; Alles J; Imig J; Zhu J; Barth S; Reineke T; Tinguely M; Cogliatti S; Dueck A; Meister G; Renner C; Grässer FA
    PLoS One; 2012; 7(8):e42193. PubMed ID: 22870299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review on natural killer/T-cell lymphoma.
    He X; Gao Y; Li Z; Huang H
    Hematol Oncol; 2023 Apr; 41(2):221-229. PubMed ID: 34731509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
    Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
    Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.